Indication
Treatment of essential hypertension. Copalia is indicated in patients whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.
Loading your page…
Loading your page…
Hypertension
Marketing Authorisation Holder: Novartis Europharm Limited
EMA Authorisation: 15/01/2007
INN: amlodipine;valsartan
AI Drug & Interaction Analysis
Free account required
Ask Osler about Copalia: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.